Ind-Swift Laboratories (NSE:INDSWFTLAB) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:INDSWFTLAB Ind-Swift Laboratories Ltd NSE:INDSWFTLAB
48 GF Score
Price ₹229.86
GF Value ₹36.76
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Ind-Swift Laboratories FFO per Share?

FFO per Share only applies to REITs.

NSE:INDSWFTLAB
48GF Score
Ind-Swift Laboratories Ltd NSE:INDSWFTLAB
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ind-Swift Laboratories (NSE:INDSWFTLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Ind-Swift Laboratories stock appears to be overvalued. The current stock price of ₹229.86 is trading 525.3% above its estimated GF Value™ of ₹36.76. GuruFocus considers Ind-Swift Laboratories to be Significantly Overvalued.

Key valuation signals for NSE:INDSWFTLAB:

  • FFO per Share:
  • GF Value™: ₹36.76 vs. price of ₹229.86 (525.3% above fair value)
  • GF Score™: 48/100 with 4 warning signs

No single metric tells the full story. See the NSE:INDSWFTLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ind-Swift Laboratories Business Description

Other Exchanges 532305:India
Address SCO 850, NAC, Shivalik Enclave, Manimajra, Chandigarh, PB, IND, 160101
Ind-Swift Laboratories Ltd is involved in manufacturing Active Pharmaceutical Ingredients (API), Intermediates, and formulations. The company serves various therapeutic segments, including Cardiovascular health, Antihistamines, Antidiabetics, Antipsychotics, Parkinson's disease, Antineoplastics, ADHD Symptoms, Analgesics, Alcohol Abstinence, and Bone Resorption Inhibitors. It operates solely in the pharmaceutical products sector. Geographically, the company supplies both domestic and international markets, with the majority of its revenue coming from outside India.
48GF Score

Get the complete analysis for NSE:INDSWFTLAB

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹229.86
Price
₹36.76
GF Value